Bill > HB2402

This bill establishes new regulations for the use of certain chemicals, specifically Di(2-ethylhexyl) phthalate (DEHP) and other ortho-phthalates, in medical equipment used for intravenous purposes in Washington state. The bill defines DEHP as a toxic chemical that can leach from plastics like polyvinyl chloride (PVC) into fluids, and it is classified as an endocrine-disrupting compound with potential links to cancer and reproductive health issues. Beginning January 1, 2030, the manufacture, sale, or distribution of intravenous solution containers containing intentionally or unintentionally added DEHP above a certain threshold will be prohibited, with a later deadline of January 1, 2035, for intravenous tubing. The bill also prohibits replacing DEHP with other ortho-phthalates and includes specific exemptions for items like blood collection bags and apheresis kits, along with provisions for delayed compliance under certain circumstances related to FDA approval or manufacturing capabilities, and temporary allowances during supply chain shortages.

Agriculture and Natural Resources, Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=2402&Year=2025&Initiative=false